-
EP2018169
European procedure
Extract from the Register of European Patents
EP About this file: EP2018169
| EP2018169 - USE OF 4,17 BETA-DIHYDROXYANDROST-4-ENE-3-ONE FOR TREATING CANCERS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 16.09.2011 Database last updated on 13.07.2024 | Most recent event Tooltip | 17.05.2013 | Lapse of the patent in a contracting state New state(s): LU | published on 19.06.2013 [2013/25] | Applicant(s) | For all designated states MaBel GmbH Henkestrasse 91 91052 Erlangen / DE | [2010/10] |
| Former [2009/05] | For all designated states Teichmann, Alexander Tobias Wallstädter Strasse 50 63762 Grossostheim / DE | Inventor(s) | 01 /
TEICHMANN, Alexander Tobias Wallstädter Strasse 50 63762 Grossostheim / DE | [2010/45] |
| Former [2010/10] | 01 /
Teichmann, Alexander Tobias Wallstädterstrasse 50 63762 Grossostheim / DE | ||
| Former [2009/05] | 01 /
see applicant ... | Representative(s) | Prüfer & Partner mbB Patentanwälte Rechtsanwälte Sohnckestrasse 12 81479 München / DE | [N/P] |
| Former [2009/05] | Prüfer & Partner GbR European Patent Attorneys Sohnckestrasse 12 81479 München / DE | Application number, filing date | 07725140.3 | 11.05.2007 | [2009/05] | WO2007EP04220 | Priority number, date | EP20060009894 | 12.05.2006 Original published format: EP 06009894 | US20060747124P | 12.05.2006 Original published format: US 747124 P | [2009/05] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007131736 | Date: | 22.11.2007 | Language: | EN | [2007/47] | Type: | A2 Application without search report | No.: | EP2018169 | Date: | 28.01.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.11.2007 takes the place of the publication of the European patent application. | [2009/05] | Type: | B1 Patent specification | No.: | EP2018169 | Date: | 10.11.2010 | Language: | EN | [2010/45] | Search report(s) | International search report - published on: | EP | 06.03.2008 | Classification | IPC: | A61K31/568, A61P5/26, A61P35/00, A61K45/06 | [2009/05] | CPC: |
A61K31/568 (EP,KR,US);
A61K45/06 (EP,KR,US);
A61P15/00 (EP);
A61P15/08 (EP);
A61P15/12 (EP);
A61P35/00 (EP);
A61P35/04 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
| C-Set: |
A61K31/568, A61K2300/00 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/05] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | VERWENDUNG VON 4,17-BETA-DIHYDROXYANDROST-4-EN-3-ON ZUR BEHANDLUNG VON KREBS | [2009/05] | English: | USE OF 4,17 BETA-DIHYDROXYANDROST-4-ENE-3-ONE FOR TREATING CANCERS | [2009/05] | French: | UTILISATION DU 4,17 BETA-DIHYDROXYANDROST-4-ENE-3-ONE POUR TRAITER LES CANCERS | [2009/05] | Entry into regional phase | 22.10.2008 | National basic fee paid | 22.10.2008 | Designation fee(s) paid | 22.10.2008 | Examination fee paid | Examination procedure | 22.10.2008 | Amendment by applicant (claims and/or description) | 22.10.2008 | Examination requested [2009/05] | 02.04.2009 | Despatch of a communication from the examining division (Time limit: M06) | 02.10.2009 | Reply to a communication from the examining division | 17.02.2010 | Communication of intention to grant the patent | 24.06.2010 | Fee for grant paid | 24.06.2010 | Fee for publishing/printing paid | Opposition(s) | 11.08.2011 | No opposition filed within time limit [2011/42] | Fees paid | Renewal fee | 29.05.2009 | Renewal fee patent year 03 | 31.03.2010 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 10.11.2010 | MT | 10.11.2010 | IS | 10.03.2011 | LU | 11.05.2011 | MC | 31.05.2011 | [2013/25] |
| Former [2012/05] | CY | 10.11.2010 | |
| MT | 10.11.2010 | ||
| IS | 10.03.2011 | ||
| MC | 31.05.2011 | ||
| Former [2011/29] | CY | 10.11.2010 | |
| IS | 10.03.2011 | Cited in | International search | [X]BE552152 (SOCIETA FARMACEUTICA ITALIA) [X] 1,2 * page 2 - page 3 * * page 3, paragraph L - page 4, paragraph 1; example 24; claim 4 *; | [DX]US2762818 (HAROLD LEVY, et al) [DX] 6 * column 2, line 14 - line 19; examples 8,9; claims 1,2 *; | [X]US2003229063 (LLEWELLYN WILLIAM CHARLES [US]) [X] 1-8 * the whole document *; | [A] - THE MERCK INDEX, WHITEHOUSE STATION, NJ, MERCK & CO., (2001), XP002403136 [A] 1-8 * page 752 * * number 4264: Formestane * | [A] - MARSH D A ET AL, "SYNTHESIS OF DEUTERIUM LABELED AND TRITIUM LABELED 4 HYDROXY ANDROSTENE-3 17-DIONE AN AROMATASE INHIBITOR AND ITS METABOLISM", BIOCHEMICAL PHARMACOLOGY, (1982), vol. 31, no. 5, ISSN 0006-2952, pages 701 - 705, XP002403133 [A] 1-8 * the whole document * | [A] - BRODIE A M H ET AL, "STUDIES ON THE MECHANISM OF ESTROGEN BIOSYNTHESIS IN THE RAT OVARY PART 1", JOURNAL OF STEROID BIOCHEMISTRY, (1976), vol. 7, no. 10, ISSN 0022-4731, pages 787 - 793, XP002403134 [A] 1-8 * the whole document * | Examination | - Klinisches Wörterbuch, 258 ed., PSCHYREMBEL | by applicant | US2744120 | US4235893 |